Showcasing the impact of cannabis on veterans, current research, and legislative affairs.
“United States veterans serve our country with pride and bravery, constantly putting themselves in dangerous and traumatic situations. When many of these men and women return back home, they face the harsh reality of the wounds they received overseas, some physical and some mental. Many veterans turn to medical marijuana as a safe alternative to addictive opioids. This guide includes everything that veterans need to know about medical marijuana treatment.”
“The fact that Pete Sessions, as chair of the House Rules Committee, has blocked the veterans Equal Access Amendment specifically and cannabis bills generally without anything as much as light admonishment from House leadership, shows where the conference’s true feelings lie.”
“Federal law prohibits VA doctors from prescribing or recommending medical marijuana to veterans,” Nelson said in a statement. “This legislation will allow veterans in Florida and elsewhere the same access to legitimately prescribed medication, just as any other patient in those 31 states would have.”
“We believe VA has the authority, ability and capacity to carry out such a study,” they wrote. “Many of our nation’s veterans already use medicinal cannabis, and they deserve to have full knowledge of the potential benefits and side effects of this alternative therapy.”
Today, Congressman Charlie Crist (D-St. Petersburg) announced the introduction of the Fairness in Federal Drug Testing Under State Laws Act (H.R.6589) with Congressman Drew Ferguson (R-GA) to protect veterans' treatment options and federal employment opportunities.
Specifically, the Marijuana Freedom and Opportunity Act removes marijuana from the list of scheduled substances under the Controlled Substances Act, effectively decriminalizing it at the federal level. The legislation allows states to continue to function as laboratories of democracy and ultimately decide how they will treat marijuana possession.
The campaign didn't appear to have significant funding from major national drug policy reform groups that have helped to pass measures in other states over several past election cycles. It also faced an opposition that poured roughly half a million dollars into television ads seeking to undermine support for medical marijuana.
The U.S. health regulator approved GW Pharmaceuticals Plc’s epilepsy treatment on Monday, making it the first cannabis-based drug to win approval in the country and opening floodgates for more research into the medicinal properties of cannabis.
“We all will face common challenges when it comes to legalizing marijuana, and those challenges need federal solutions so implementation can be done smoothly, safely and effectively.”
“Outdated federal marijuana laws have perpetuated our broken criminal justice system, created barriers to research, and hindered economic development,” Warren said in a press release.